Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 1755

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 7A
Chunk 1755
---
     0.13 
  
    Volatility 
     90% 
     90% 
     90%
  
    Risk-free rate 
     N/A  
     4.70% 
     5.00%
  
    Probability of IPO 
     60% 
     60% 
     60%
  
    Derivative liability, measurement input 
     60% 
     60% 
     60%

    F-17

JUPITER
NEUROSCIENCES, INC.

NOTES
TO FINANCIAL STATEMENTS

December
31, 2024 and 2023

Note
5 – Convertible Debt and Derivative Liability, continued

Derivative
Liability Pursuant to Convertible Debt, continued

A
summary of activity of the derivative liability pertaining to the Notes is presented below:

Schedule
of Derivative Liability

    Derivative Liability 
  
    Balance at December 31, 2022 
    $710,599 
  
    Fair value at issuance March 1, 2023 
     55,604 
  
    Fair value adjustment on date of amendment, net 
     887,946 
  
    Fair value change 
     (148,751)
  
    Balance at December 31, 2023 
    $1,505,398 
  
    Fair value change 
     53,257 
  
    Extinguishment of derivative liability - Note II 
     (1,359,362)
  
    Fair value at issuance on April 29, 2024 - Senior Secured Note 
     407,494 
  
    Repayment of derivative liability 
     (606,787)
  
    Fair value at issuance 
     407,494 
  
    Derivative liability  Balance  
    $606,787 

    Balance at December 31, 2024 
    $-
  
    Derivative liability Balance  
    $- 

Note
6 – Stockholders’ Equity (Deficit)

Common
Stock

The
Company is authorized to issue 125,000,000 shares of common stock and 5,000,000 shares of preferred stock. The Company had 33,103,860
shares of common stock issued and outstanding as of December 31, 2024. There was no preferred stock issued and outstanding as of December
31, 2024.

On
June 3, 2024, the Company entered